News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
New and experimental HIV treatments
Long-Lasting HIV Drug Could Change Therapy

An extremely long-lasting anti-HIV drug has the potential to alter both treatment and prevention of the virus, researchers said at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy. The investigational integrase inhibitor S/GSK744 might need to be given only every 3 months.

Published
13 September 2012
From
MedPage Today
PrEP
Analysis: Use of pill to prevent HIV may be limited in US

The first preventive pill for HIV has been hailed as a landmark in the fight against AIDS in the United States, but experts say only a small percentage of those at risk will benefit from it.

Published
10 September 2012
From
Reuters
Conception
Revised DHHS Guidelines for Perinatal Antiretroviral Use

The new guidelines offer more treatment options for pregnant HIV-infected women and explore the range of options available for safe conception in HIV-serodiscordant couples.

Published
03 September 2012
From
Journal Watch HIV/AIDS Clinical Care
PrEP
Nigeria: Expert Expresses Concern Over Truvada

In her words: "With the awareness of Truvada as treatment of HIV, our people would throw caution into the wind and go all out in promiscuity. This is my personal opinion but I know very well that the society is not ripe for such drug at this time."

Published
28 August 2012
From
AllAfrica
How transmission occurs
Low levels of innate immune activation and high levels of gut antibodies may protect people from HIV

Several research papers published in the last month have reported strong correlations between specific immune responses and protection against HIV infection or its effects. These include

Published
24 August 2012
By
Gus Cairns
PrEP
High levels of maraviroc in rectal tissue fail to protect macaques from SIV transmission following rectal exposure

A poster at the Wahington International AIDS Conference from the group responsible for key animal studies looking at tenofovir and/or FTC for PrEP presented a poster with disappointing findings for the entry-inhibitor drug maraviroc. Despite high levels of maraviroc in tissues there no evidence for prophylactic efficacy: 5/6 treated animals and 3/4 controls became infected over the five weeks.

Published
24 August 2012
From
HIV i-Base
PrEP
PrEP Talk 101

A pill prevents getting HIV? Here's what you need to know about Truvada, the HIV med the FDA just approved as pre-exposure prophylaxis (PrEP).

Published
17 August 2012
From
Aidsmeds
PrEP
QUESTION: Should PrEP Treatments Like Truvada Be Encouraged For HIV?

Should PrEP Treatments Like Truvada Be Encouraged For HIV? Gay blog is not keen.

Published
16 August 2012
From
Queerty
PrEP
HIV prevention pill for heterosexuals at risk too

U.S. health officials said Thursday that doctors should consider giving an AIDS prevention pill to women and heterosexual men who are at high risk for getting the virus. The government previously advised doctors to give the once-a-day pill Truvada to high-risk gay and bisexual men only. However, more than a quarter of new HIV cases each year are heterosexuals, according to the Centers for Disease Control and Prevention. "That's not a portion of the epidemic we want to ignore," said Dr. Dawn Smith, the CDC physician who was lead author of the new guidance.

Published
10 August 2012
From
Associated Press
Men who have sex with men (MSM)
What kind of prevention do gay men need?

A number of presentations at the 19th International AIDS Conference explored the 'hyperepidemic' of HIV amongst men who have sex with men, and especially black MSM. A paper

Published
06 August 2012
By
Gus Cairns
← Prev1...34567...24Next →

Filter by country